Hormone Receptor-Positive Breast Cancer Clinical Trials
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
Hormone Receptor-Positive Breast CancerHigh-risk Breast Cancer
Peking University People's Hospital393 enrolled1 locationNCT06970912
Recruiting
Phase 2
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Hormone Receptor-Positive Breast Cancer
Rutgers, The State University of New Jersey40 enrolled7 locationsNCT06518837
Recruiting
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
Metastatic Breast CancerHER2-positive Breast CancerHormone Receptor-Positive Breast Cancer+1 more
Hunan Cancer Hospital200 enrolled1 locationNCT07073755